PP 2.2 – 00024 Evaluation of an NNRTI-mediated Targeted Activated Cell Kill (TACK) in a Viremic Mouse Model

• J. Maxwell,
• L. Sardo,
• G. Wu,
• D. Dooney,
• S. Polsky-Fisher,
• B.J. Howell,
• J. Grobler,
• C.J. Balibar,
• P. Zuck

Affiliations

J. Maxwell

M Merck & Co., Inc., Rahway, NJ, USA

L. Sardo

M Merck & Co., Inc., Rahway, NJ, USA

G. Wu

M Merck & Co., Inc., Rahway, NJ, USA

D. Dooney

M Merck & Co., Inc., Rahway, NJ, USA

S. Polsky-Fisher

M Merck & Co., Inc., Rahway, NJ, USA

B.J. Howell

M Merck & Co., Inc., Rahway, NJ, USA

J. Grobler

M Merck & Co., Inc., Rahway, NJ, USA

C.J. Balibar

M Merck & Co., Inc., Rahway, NJ, USA

P. Zuck

M Merck & Co., Inc., Rahway, NJ, USA